Suchergebnisse - "Mycock, Katie"

PubPharm (15)

1

Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings : Results from the TANDEM Study

enthalten in: Infectious diseases and therapy | 2024

von Schneider, S. | Blick, G. | Burke, C. | +13

2

Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads : TANDEM Study Subgroup Analyses

enthalten in: Infectious diseases and therapy | 2024

von Benson, P. | Kuretski, J. | Donovan, C. | +8

3

Real-world Treatment Patterns and Clinical Outcomes Associated With Palbociclib Combination Therapy : A Multinational, Pooled Analysis From the Ibrance Real World Insights Study

enthalten in: Clinical therapeutics | 2022

von Mycock, K. | Hanson, K. | Taylor-Stokes, G. | +5

4

Treatment and disease management patterns for bacillus Calmette-Guérin unresponsive nonmuscle invasive bladder cancer in North America, Europe and Asia : A real-world data analysis

enthalten in: Current urology | 2022

von Broughton, E. | Chun, D. | Gooden, K. | +3

5

People living with moderate-to-severe COPD prefer improvement of daily symptoms over the improvement of exacerbations : a multicountry patient preference study

enthalten in: ERJ open research | 2022

von Cook, N. | Criner, G. | Burgel, P. | +14

6

Multi-country clinical practice patterns, including use of biomarkers, among physicians' treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)

enthalten in: BMC urology | 2022

von Broughton, E. | Gooden, K. | Mycock, K. | +2

7

Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)

enthalten in: BMC urology | 2022

von Broughton, E. | Gooden, K. | Mycock, K. | +2

8

Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)

enthalten in: BMC urology | 2022

von Broughton, E. | Gooden, K. | Mycock, K. | +2

9

Real-world treatment of patients with palbociclib for HR+/HER2-advanced/metastatic breast cancer : the Europe IRIS study

enthalten in: Future oncology (London, England) | 2022

von Mycock, K. | Zhan, L. | Hart, K. | +4

10

Real-world treatment patterns and clinical outcomes in patients receiving palbociclib combinations for HR+/HER2- advanced/metastatic breast cancer in Japan : Results from the IRIS study

enthalten in: Cancer treatment and research communications | 2022

von Mycock, K. | Zhan, L. | Hart, K. | +4